Literature DB >> 7639553

Lipid profile with paternal history of coronary heart disease before age 40.

T Bistritzer1, L Rosenzweig, J Barr, S Mayer, E Lahat, H Faibel, Z Schlesinger, M Aladjem.   

Abstract

Serum lipids were measured in children and their parents from 40 families in which the father had a myocardial infarction or coronary heart disease (CHD) before age 40 years. The relationship between physical activity and serum lipid concentrations in the children was also evaluated. Twenty six men had one or more abnormal lipid value (in mmol/l): total venous cholesterol (TVC) > 6.24, triglycerides < 2.55, low density lipoprotein cholesterol (LDL-C) > 4.42, or high density lipoprotein cholesterol (HDL-C) < 0.91. There were 15 spouses with significant hyperlipidaemia (values above). In the 107 children examined, TVC mean (SD) was 4.68 (1.17), triglycerides 1.4 (0.8), LDL-C 3.0 (1.0), and HDL-C 1.18 (0.28). Altogether 42% of the children had significant hyperlipidaemia. No significant correlation was found between the degree of physical activity of the children and their LDL-C and TVC concentrations. However, a significant positive correlation was found between the degree of physical activity and HDL-C and a significant negative one with triglyceride concentrations. It is concluded that screening the progeny of young CHD patients is highly productive in identifying young people at excessive risk for future CHD. The data also suggest that promoting high degrees of activity among these children may have a positive influence on risk factors for adult onset CHD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7639553      PMCID: PMC1511160          DOI: 10.1136/adc.73.1.62

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  20 in total

1.  Current concepts in genetics. The genetic hyperlipidemias.

Authors:  A G Motulsky
Journal:  N Engl J Med       Date:  1976-04-08       Impact factor: 91.245

2.  Exercise, lipids, and obesity in adolescents with parental history of coronary disease.

Authors:  K J Stewart; A P Goldberg
Journal:  Am J Health Promot       Date:  1992 Jul-Aug

3.  Serum lipids and lipoproteins in children from families with early coronary heart disease.

Authors:  I Tamir; Y Bojanower; O Levtow; D Heldenberg; Z Dickerman; B Werbin
Journal:  Arch Dis Child       Date:  1972-10       Impact factor: 3.791

4.  Screening for hyperlipidemia in childhood.

Authors:  H P Chase; R J O'Quin; D O'Brien
Journal:  JAMA       Date:  1974-12-16       Impact factor: 56.272

5.  Hyperlipemia in progeny of parents with myocardial infarction before age 50.

Authors:  C J Glueck; R W Fallat; R Tsang; C R Buncher
Journal:  Am J Dis Child       Date:  1974-01

6.  Lipid and carbohydrate abnormalities in patients with angiographically documented coronary artery disease.

Authors:  R A Heinle; R I Levy; D S Frederickson; R Gorlin
Journal:  Am J Cardiol       Date:  1969-08       Impact factor: 2.778

7.  Genetic--epidemiologic study of early-onset ischemic heart disease.

Authors:  J J Nora; R H Lortscher; R D Spangler; A H Nora; W J Kimberling
Journal:  Circulation       Date:  1980-03       Impact factor: 29.690

8.  Cholesterol screening of seven-year-old children. How to identify children at risk.

Authors:  B Larsson; I Vaara
Journal:  Acta Paediatr       Date:  1992-04       Impact factor: 2.299

9.  The effect of weight control on lipid changes in obese children.

Authors:  L H Epstein; L H Kuller; R R Wing; A Valoski; J McCurley
Journal:  Am J Dis Child       Date:  1989-04

10.  The association between physical fitness and cardiovascular disease risk factors in children in a five-year follow-up study.

Authors:  A Hofman; H J Walter
Journal:  Int J Epidemiol       Date:  1989-12       Impact factor: 7.196

View more
  1 in total

Review 1.  A systematic review and meta-analysis on screening lipid disorders in the pediatric age group.

Authors:  Roya Kelishadi; Ali Akbar Haghdoost; Mahmood Moosazadeh; Mojtaba Keikha; Maryam Aliramezany
Journal:  J Res Med Sci       Date:  2015-12       Impact factor: 1.852

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.